返信投稿
nyn*bytf@gmail.com
toms Sko online
8/1(土) 00:51:42 No.20150801005142
retention in the tumor tissue as compared to doxorubicin. These data, combined with aldoxorubicin favorable safety profile, support the current evaluation of aldoxorubicin as a treatment for patients
名前
パスワード
コメント
|
もどる
|